Copyright
©The Author(s) 2019.
World J Gastrointest Surg. Jun 27, 2019; 11(6): 287-295
Published online Jun 27, 2019. doi: 10.4240/wjgs.v11.i6.287
Published online Jun 27, 2019. doi: 10.4240/wjgs.v11.i6.287
Inclusion criteria |
a) 1 lesion > 5 cm and ≤ 8 cm |
b) 2 or 3 lesions, at least one > 3 cm but ≤ 5 cm + the total tumor diameter ≤ 8 cm |
c) 4 or 5 lesions, all ≤ 3 cm + the total tumor diameter ≤ 8 cm |
d) No vascular invasion on imaging |
Criteria for successful down-staging |
Tumor size and number need to satisfy the UNOS T2 criteria |
Complete tumor necrosis without contrast enhancement to suggest residual tumor, equivalent to obliteration of the tumor irrespective of the tumor size |
Additional guidelines |
1) A minimum observation period of 3 mo after down-staging is required before deceased donor liver transplantation, and if imaging studies meet the above-mentioned criteria for successful down-staging |
2) Patients can undergo live donor liver transplantation at 3 mo after down-staging, and if imaging studies satisfy the UCSF criteria |
3) Those with acute hepatic decompensation after the down-staging procedure are not eligible for liver transplantation unless they satisfy the abovementioned criteria |
- Citation: Mullath A, Krishna M. Hepatocellular carcinoma – time to take the ticket. World J Gastrointest Surg 2019; 11(6): 287-295
- URL: https://www.wjgnet.com/1948-9366/full/v11/i6/287.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v11.i6.287